New cancer treatment fools the immune system to attack
NeoTX, whose team includes several Nobel laureates, is testing a cancer-fighting approach that uses bacteria to bait the immune system into an attack.
Source: israel21c.org
Stay updated with breaking news from Marcel Rozencweig. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NeoTX, whose team includes several Nobel laureates, is testing a cancer-fighting approach that uses bacteria to bait the immune system into an attack.
Biotech company NeoTXis' Tumor Targeted Superantigen (TTS) technology works to kill cancer cells in a way that no other available cancer treatment can.
/PRNewswire/ -- NeoTX Therapeutics (NeoTX), a clinical-stage immuno-oncology company, announced the promotion of current CMO, Marcel Rozencweig, M.D., to...